Herbalife Ltd. HLF R2K

Consumer Defensive · Packaged Foods · United States

https://www.herbalife.com

Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.

Market & Price

Market Cap

$1.24B

Current Price

$11.96

High / Low (52W)

$19.96 / $7.44

Beta

0.99

Valuation

Stock P/E

5.25

Industry PE

18.88

Forward P/E

3.79

PEG Ratio

0.61

Book Value

$-4.27

Price to Book

-2.80

P/S

0.24

EV/EBITDA

4.71

Dividend Yield

Profitability & Returns

ROCE

27.61%

ROE

ROA

11.51%

Profit Margin

4.67%

Op Margin

10.69%

EPS (Latest Qtr)

$0.57

EPS (TTM)

$2.28

Balance Sheet & Liquidity

Debt/Equity

Quick Ratio

0.56

Current Ratio

1.23

Debt

$2.18B

Total Assets

$2.79B

Current Assets

$1.14B

Working Capital

$131.80M

Ownership

Promoter Holding

5.06%

Chg in Prom Hold

FII / Inst Holding

102.77%

Chg in FII Hold

Financial Snapshot

Enterprise Value

$2.98B

Total Revenue (TTM)

$5.13B

EBITDA

$631.70M

Free Cash Flow

$348.96M

Operating Cash Flow

$446.90M

Shares Outstanding

103.67M

Gross Margin

77.78%

Payout Ratio

0.00%

Growth (CAGR)

Revenue 5Y

-1.08%

Profit 5Y

-10.77%

Revenue (YoY)

7.80%

Earnings (YoY)

16.30%

PROS

Healthy ROCE of 27.6%.
Generates positive free cash flow.
In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Revenue declined at -1.1% CAGR over 5 years.
Earnings shrank at -10.8% CAGR over 5 years.
Trading 40.1% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Consumer Defensive).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	HLF Herbalife Ltd. R2K	11.96	5.25	$1.24B	-	27.61%	-	-1.08%	-10.77%
2	WMT Walmart Inc. SPX	115.75	40.76	$922.64B	0.86%	18.21%	24.13%	5.27%	23.30%
3	COST Costco Wholesale Corporation NDXSPX	956.32	49.76	$424.27B	0.61%	27.44%	29.65%	6.64%	11.49%
4	KO The Coca-Cola Company SPX	79.01	24.85	$339.94B	2.68%	21.13%	43.37%	3.69%	11.16%
5	PG The Procter & Gamble Company SPX	143.56	21.02	$334.29B	2.97%	23.63%	31.11%	1.67%	2.71%
6	PM Philip Morris International Inc. SPX	177.38	24.98	$276.46B	3.31%	35.35%	-	8.57%	7.84%
7	PEP PepsiCo, Inc. NDXSPX	144.19	22.64	$197.10B	4.11%	15.23%	43.88%	2.83%	-2.57%
8	MO Altria Group, Inc. SPX	69.58	14.53	$116.19B	6.09%	40.85%	-	-0.89%	6.42%
9	MNST Monster Beverage Corporation NDXSPX	88.08	42.55	$86.14B	-	28.33%	26.65%	9.54%	16.94%

Quarterly Results

Figures in USD.

Metric	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	1.10B	1.15B	1.09B	1.09B	1.18B	1.29B	1.24B	1.19B	1.17B	1.24B	1.24B	1.22B	1.26B	1.35B	1.52B	1.41B	1.50B	1.55B	1.43B	1.34B	1.39B	1.30B	1.25B	1.31B	1.28B	1.26B	1.28B	1.24B	-	1.22B	1.26B	1.27B	1.28B	1.32B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	265.20M	276.90M	284.20M	288.30M	291.10M
Gross Profit	896.00M	894.00M	906.50M	965.50M	912.90M	848.90M	897.50M	928.10M	870.00M	883.50M	937.00M	1.05B	1.02B	960.70M	930.60M	996.90M	1.00B	990.50M	1.02B	1.07B	1.20B	1.10B	1.19B	1.23B	1.13B	1.03B	1.08B	1.01B	953.50M	1.01B	978.10M	979.30M	998.00M	971.60M	-	956.50M	982.20M	989.50M	994.70M	1.03B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	833.70M	849.60M	863.70M	894.90M	887.70M
Operating Income	161.60M	-	168.30M	-19.90M	151.50M	-	143.80M	204.90M	119.30M	-	155.80M	191.80M	187.30M	-	163.00M	153.10M	143.60M	-	95.60M	189.70M	206.90M	-	222.50M	237.90M	189.40M	153.10M	155.80M	147.40M	70.50M	123.40M	106.70M	71.90M	80.40M	127.10M	-	122.80M	132.60M	125.80M	99.80M	138.40M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	156.10M	164.90M	158.50M	131.20M	170.50M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	54.60M	55.40M	53.00M	51.40M	49.50M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70.80M	79.00M	74.80M	50.50M	91.60M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20.40M	29.80M	31.70M	-34.60M	30.40M
Net Income	93.60M	84.50M	95.80M	-22.90M	87.70M	99.40M	85.20M	137.60M	54.50M	-63.40M	82.10M	94.40M	71.20M	48.90M	96.30M	76.50M	81.50M	56.70M	45.60M	115.10M	138.10M	73.80M	147.40M	144.20M	117.40M	98.20M	86.50M	82.20M	29.30M	59.90M	42.80M	24.30M	4.70M	47.40M	-	50.40M	49.30M	43.20M	85.60M	61.20M
Diluted EPS	1.09	0.98	1.12	-0.28	1.01	1.16	0.49	0.81	0.33	-0.43	0.54	0.62	0.49	0.34	0.66	0.54	0.58	0.40	0.32	0.82	1.04	0.59	1.33	1.31	1.09	0.96	0.88	0.83	0.29	0.60	0.43	0.24	0.05	0.46	-	0.49	0.48	0.42	0.81	0.57

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	4.49B	4.43B	4.89B	4.88B	5.54B	-	5.20B	5.06B	4.99B	5.04B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.17B	1.19B	1.10B	1.11B
Gross Profit	1.90B	1.83B	2.18B	2.77B	3.26B	3.86B	3.98B	3.61B	3.63B	3.58B	3.97B	3.92B	4.39B	-	4.03B	3.87B	3.89B	3.92B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.49B	3.52B	3.50B	3.44B
Operating Income	332.25M	296.03M	387.51M	562.27M	661.40M	735.30M	513.50M	583.60M	458.10M	617.10M	683.10M	568.10M	640.60M	-	545.20M	356.40M	385.90M	481.00M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	679.50M	482.20M	509.10M	610.70M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	139.30M	165.90M	218.30M	214.40M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	424.80M	203.00M	169.40M	275.10M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	103.50M	60.80M	-84.90M	47.30M
Net Income	221.19M	203.35M	299.21M	414.96M	464.00M	527.50M	308.70M	339.10M	260.00M	213.90M	296.60M	311.00M	372.60M	-	321.30M	142.20M	254.30M	228.30M
Diluted EPS	3.36	1.61	2.37	3.32	3.94	4.91	3.40	3.97	1.51	1.29	1.98	2.20	2.77	-	3.23	1.42	2.50	2.20

Compounded Sales Growth

5 Years:	-1.08%
1 Year:	7.80%

Compounded Profit Growth

5 Years:	-10.77%
1 Year:	16.30%

Stock Price Performance

1 Year:	+53.14%
6 Months:	+1.10%
3 Months:	-38.73%
1 Month:	-25.16%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	1.15B	1.23B	1.45B	1.72B	2.47B	2.35B	2.48B	2.57B	2.90B	2.79B	2.68B	3.08B	-	2.73B	2.81B	2.73B	2.79B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.36B	1.40B	1.14B	1.14B
Cash & Equivalents	187.41M	150.85M	150.80M	190.55M	258.80M	333.50M	973.00M	645.40M	889.80M	844.00M	1.28B	1.20B	839.40M	1.05B	-	508.00M	575.20M	415.30M	353.10M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	580.70M	505.20M	475.40M	511.70M
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	70.60M	81.20M	68.90M	91.90M
Total Liabilities	-	-	786.74M	745.01M	886.02M	1.33B	1.92B	2.69B	2.53B	2.37B	3.23B	3.51B	3.07B	3.93B	-	4.00B	3.87B	3.53B	3.30B
Current Liabilities	-	-	429.97M	470.82M	548.69M	762.36M	922.30M	874.80M	1.02B	791.50M	906.80M	1.59B	964.40M	1.13B	-	976.60M	1.28B	1.23B	1.01B
Long Term Debt	-	-	-	-	-	-	850.00M	1.69B	1.39B	1.44B	2.17B	1.77B	1.78B	2.41B	-	2.66B	2.25B	1.98B	1.97B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.92B	2.77B	2.47B	2.18B
Total Equity	182.24M	241.73M	359.31M	474.00M	548.20M	395.50M	551.40M	-334.40M	-53.50M	196.30M	-334.70M	-723.40M	-390.00M	-856.10M	-	-1.27B	-1.06B	-801.10M	-515.10M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	97.90M	99.20M	101.20M	103.31M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	272.99M	285.06M	389.08M	510.54M	567.78M	772.88M	-	-	367.30M	590.80M	648.40M	457.50M	628.60M	-	352.50M	357.50M	285.40M	333.30M
Investing Cash Flow	-84.96M	-71.32M	-69.14M	-92.09M	-125.00M	-150.82M	-	-	-142.40M	-95.20M	-83.90M	-108.00M	-123.20M	-	-156.20M	-134.80M	-84.60M	-108.70M
Financing Cash Flow	-205.07M	-213.33M	-263.16M	-339.01M	-371.24M	30.74M	-	-	-252.30M	-85.20M	-593.10M	-713.00M	-320.90M	-	-264.70M	-148.30M	-335.30M	-295.50M
Capital Expenditure	-88.60M	-59.77M	-68.12M	-90.41M	-121.50M	-146.90M	-173.70M	-79.00M	-143.40M	-95.50M	-84.00M	-106.10M	-112.00M	-	-156.40M	-135.00M	-122.00M	-80.40M
Free Cash Flow	184.39M	225.29M	320.96M	420.13M	446.28M	625.98M	-	-	223.90M	495.30M	564.40M	351.40M	516.60M	-	196.10M	222.50M	163.40M	252.90M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-68.40M	74.40M	-134.50M	-70.90M
Share Buybacks	138.92M	74.64M	160.01M	321.64M	556.80M	306.50M	1.29B	16.60M	13.20M	844.20M	750.30M	16.70M	923.50M	1.01B	146.70M	11.00M	8.30M	8.20M

Ratios (Annual)

Figures in %.

Metric	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	81.0%	80.8%	81.2%	80.4%	79.2%	-	77.4%	76.5%	77.9%	77.9%
Operating Margin %	-	-	-	-	-	-	-	-	10.2%	13.9%	14.0%	11.6%	11.6%	-	10.5%	7.0%	7.7%	9.5%
Net Margin %	-	-	-	-	-	-	-	-	5.8%	4.8%	6.1%	6.4%	6.7%	-	6.2%	2.8%	5.1%	4.5%
ROE %	91.5%	56.6%	63.1%	75.7%	117.3%	95.7%	-92.3%	-633.8%	132.5%	-63.9%	-41.0%	-79.7%	-43.5%	-	-25.4%	-13.4%	-31.7%	-44.3%
ROCE %	-	41.3%	50.9%	62.6%	68.8%	47.4%	34.7%	40.2%	25.8%	31.0%	56.9%	33.1%	32.9%	-	31.1%	23.3%	25.8%	27.1%

Shareholding Pattern

Insiders

5.06%

Institutions

102.77%

Public Float

108.25%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	BAUPOST GROUP LLC/MA	8.93%	9.26M	$110.75M
2	Route One Investment Company, L.P.	7.94%	8.23M	$98.40M
3	Blackrock Inc.	7.54%	7.82M	$93.55M
4	Vanguard Portfolio Management LLC	5.87%	6.09M	$72.79M
5	Renaissance Technologies, LLC	5.31%	5.50M	$65.78M
6	FMR, LLC	5.08%	5.27M	$62.99M
7	Vanguard Capital Management LLC	4.26%	4.41M	$52.79M
8	Goldman Sachs Group Inc	3.02%	3.13M	$37.48M
9	Geode Capital Management, LLC	2.54%	2.63M	$31.44M
10	LSV Asset Management	2.53%	2.63M	$31.41M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HLF

No recent headlines available.

HLF · Consumer Defensive

Herbalife Ltd.

About

Key Facts

Sector	Consumer Defensive
Industry	Packaged Foods
Headquarters	United States
Employees	8,500
Website	https://www.herbalife.com

Press Esc or click outside to close.

Explore More

📊 Consumer Defensive Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Herbalife Ltd. HLF R2K

Market & Price

Valuation

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Growth (CAGR)

PROS

CONS

Price Chart

Technical Trend

Fundamental Growth

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Explore More